Asish K. Xavier

Asish Xavier, Ph.D. is Vice President, Venture Investments, and he joined Johnson & Johnson Development Corporation in 2004. Dr. Xavier previously worked in business development at BioRexis Pharmaceutical Corporation which was acquired by Pfizer in 2007. While at BioRexis, he assisted the company in raising a $30 million second round of financing. Dr. Xavier has worked in business development at Structural GenomiX, Inc., acquired by Eli Lilly in 2008, and was a project leader at Message Pharmaceuticals, Inc. Dr. Xavier received a Ph.D. from the University of Houston and an MBA from the Wharton School of the University of Pennsylvania, where he graduated with honors. He received a Bachelor of Technology in chemical engineering from the Indian Institute of Technology, Kanpur, India. Dr. Xavier was a postdoctoral research fellow in the Department of Chemistry at the Johns Hopkins University.